Crystal structures of ASK1‐inhibtor complexes provide a platform for structure‐based drug design
暂无分享,去创建一个
I. Wall | P. Rowland | R. Tanner | T. Skarzynski | O. Singh | Kathrine J. Smith | P. Craggs | Anthony Shillings | Clare I. Hobbs | P. Hardwick | M. Blunt | D. Witty | David R. Witty